Glasgow, Scotland, UK, 20th June 2016: Mironid Ltd, a leader in cell signalling directed drug development, today announced the closing of its Series A funding
Caldan Therapeutics, a spin-out company from the Universities of Glasgow and Southern Denmark, which specialises in developing novel therapeutics targeting free fatty acid receptors for
By Gareth Mackie, The Scotsman A university spin-out that specialises in potential treatments for type 2 diabetes has bolstered its boardroom in the wake of
Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical
Hamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This
Edinburgh, United Kingdom, 9th March, 2016 – Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the
Louisville, Ky., Feb. 12, 2016 – Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new
By Varun Saxena, FierceMedicalDevices December 10, 2015 – Harpoon Medical Executive Vice President Peter Boyd told FierceMedicalDevices that cardiology titan Edwards Lifesciences acquired an option
By Varun Saxena, FierceMedicalDevices December 9, 2015 – Just as the flurry of M&A activity in the transcatheter mitral valve repair arena appears to be
Glasgow, United Kingdom, November 4th 2015 – Caldan Therapeutics Ltd (Caldan) has announced a £4.45 million ‘Series A’ investment led by Epidarex Capital, a leading